search

JCR Pharmaceuticals, a Japanese public company engaged in research, development, manufacture and sales of pharmaceuticals, has chosen Luxembourg to set up a new manufacturing plant of Active Pharmaceuticals Ingredients (APIs). The project is strategic investment for JCR in view of the global development of the company’s therapeutic enzyme products to which J-Brain Cargo®, JCR’s proprietary blood-brain-barrier technology, is applied, and aims the reinforcement of manufacturing sites for future products under development.

The new plant in Luxembourg will be the first step for JCR in establishing a global framework of its manufacturing operations outside of Japan. The company is engaged on a growth trajectory in Japan, it employs more than 500 people and its annual turnover is over 136 million euro.

The Deputy Prime Minister, Minister of the Economy, Étienne Schneider has met the management of JCR Pharmaceuticals in Luxembourg and during the State visit to Japan in November 2017. Following up on those meetings, the Luxembourg Government and JCR Pharmaceuticals now signed a Memorandum of Understanding (MoU) relating to a surface right on industrial land of the Ministry of Economy in the industrial park “Bommelscheuer” located in the municipality of Käerjeng.

“I am honored to have signed this MoU with the Grand-Duchy of Luxembourg. I believe that setting up an API manufacturing plant for our biomedicine in Luxembourg will be essential for the company’s global development. Being able to deliver the JCR-branded medicine from this plant to patients in the world is what I hope to see in the future,” said Shin Ashida, Representative Director, Chairman, President and CEO.

Deputy Prime Minister and Minister of the Economy, Étienne Schneider, stated: “The implementation of JCR in Luxembourg is in line with our positioning as a strategic hub to access the European market and with our focus on health technologies as one of the threads of our economic development strategy. The State visit to Japan was an excellent opportunity to consolidate the relationship between the Ministry of Economy and JCR and I am convinced that their implementation in Luxembourg will be to our mutual benefit. “

Read more

EHDS: A new EU framework for digital health innovation

02-04-2025

The impact of the forthcoming European Health Data Space was the main topic of the European Digital Healthtech Conference 2025, hosted in Luxembourg.
Read more

FM to build science and technology centre in Luxembourg

18-03-2025

Insurance company FM chose a strategically located European hub for its scientific research facility focusing on risk management and risk mitigation innovation.
Read more

Luxembourg to build AI-optimised supercomputer

11-03-2025

The Ministers of Economy and Research presented the roadmap for the national supercomputer optimised for artificial intelligence and the associated AI Factory.
Read more

AciesNova’s 5G solution takes root in Luxembourg

11-03-2025

The company offers an alternative 5G solution for public and private networks and has incorporated in Luxembourg to benefit from its stable business environment.
Read more

Luxembourg startup speeds up drug discovery using AI models

18-02-2025

Helical has trained a state-of-the-art mRNA bio foundation model to accelerate mRNA therapy research, outperforming similar models from leading pharma companies.
Read more

Resources all news

Fermer